The concept of reprogramming of somatic cells has opened a new era in regenerative medicine. Transduction of defined factors has successfully achieved pluripotency.
INTRODUCTION
Stem cells are a promising source of biological material for regenerative medicine. The concept of producing autologous or customized pluripotent stem cells from somatic cells has attracted the attention of investigators and clinicians who seek a feasible methodology for cell therapy that can be applied to the treatment of patients with degenerative diseases and organ failure as well as experimental applications for drug discovery, screening and toxicology, etc.
Epoch-making discoveries in the reprogramming of mouse as well as human somatic cells into pluripotent stem cells (induced pluripotent stem cells, iPS cells), by viral transduction of certain transcription factors, has opened a new-era of regenerative medicine. [1] [2] [3] [4] [5] [6] However, there is concern that the retroviral or lentiviral introduction of defined factors could cause unexpected long-term instability and tumorigenicity due to permanent genetic integration. 7, 8 These critical issues remain to be addressed prior to clinical application. Therefore, there is currently ongoing an extensive search for new methods such as a reduced number of defined factors, 9 adenoviral or plasmid-based transient gene delivery [10] [11] [12] , or oocyte-free, non-viral inducers like small molecules [13] [14] [15] and proteins 16 that could be safely used in this context. Meiotic oocyte and mitotic zygote cytoplasm can induce the reprogramming of somatic cell within a short period of time and a few cell divisions after nuclear transfer whereas ectopic expression of a limited number of certain transcription factors needed a long period and multiple cell divisions to achieve full reprogramming. [17] [18] [19] [20] In this study, we hypothesized that the proteins of actively proliferating ES cells, which has yet to be precisely determined, could have the capacity to induce reprogramming of adult somatic Previous studies using various cellular proteins or extracts have shown a modest effect on reprogramming into specific lineages 21, 22 or dedifferentiation into the pluripotent state. 23 The reprogrammed multipotent cells produced by transferring extracts of embryonic carcinoma or ES cell did not reach the pluripotent state in terms of the transcriptional state, in vivo three germ layer differentiation capacity and developmental potential. 23, 24 Here, we investigated whether a single transfer of ES cell-derived extract proteins into primarily cultured adult somatic cells, rather than repeated transfer or prolonged exposure to materials, could achieve full reprogramming up to the pluripotent state. We demonstrate that protein-mediated reprogrammed adult fibroblasts (protein-iPS) are biologically and functionally very similar to ES cells in vitro, and possess in vivo differentiation and developmental potentials including well-differentiated teratoma formation, contribution to chimeras and tetraploid blastocyst complementation. These results may provide a simple, safe and effective alternative strategy for dedifferentiation or reprogramming of adult somatic cells.
METHODS

Animals
C57BL/6 and FVB strain wild type mice and Oct4-promoter-driven GFP mice (Jackson Laboratory) were used for primary cardiac and skin fibroblast preparations. Nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice (Jackson Laboratory)
were used for teratoma formation. All animal experiments were performed after Table   5 ). 23, 24 Typically, 20-35 mg/ml of proteins were used to induce reprogramming. To 
Analysis of mRNA expression
Global gene expression analyses were performed using Affymetrix GeneChip® Mouse Gene 
DNA methylation and chromatin analysis
To assess the methylation status of Oct4 and Nanog promoters, bisulfite sequencing was performed as described previously. 26, 27 For chromatic immunoprecipitation (ChIP) assays of Oct4 and Nanog promoters, 1x10 6 cells were crosslinked and quenched using 1% formaldehyde and glycine 1 
protein-iPS cell and between adult fibroblast and protein-iPS cell was examined by
Pearson correlation coefficients.
In vitro and in vivo differentiation
To assess the in vitro differentiation potential, cell aggregates generated in suspension culture (embryoid body) were plated onto 0.1% gelatin-coated tissue culture dishes and cultured. Morphologically, some spontaneously contracting embryonic bodies were filmed (OLYMPUS 1X71 and Olympus DP71 Digital Camera, 15 fps at 680 x 512). The gene and protein expression for markers found in the three germ layers were examined by RT-PCR and immunocytochemistry. To examine in vivo differentiation potential, 1x10 7 of the protein-iPS cells were injected subcutaneously into the backs of NOD/SCID mice and the histology was reviewed.
Blastocyst injection, chimaera generation and tetraploid complementation
To determine the in vivo developmental potentials, chimaeric mice was generated using the FVB strain of protein-iPS cells with standard ES-cell transfer procedures for the production of chimaeras (Macrogen, Seoul, Korea). Typically, 8 to 10 cells were injected into the C57BL/6 blastocyst cavity and transferred to the uterus of pseudopregnant ICR females on 2.5 dpc. 28 The combination of the -sFB-protein-iPS cells with C57BL/6 host blastocysts resulted in black/white-colored chimaeric mice. To verify the pluripotency of the reprogrammed cells, a tetraploid blastocyst complementation experiment was performed. 29, 30 Diploid GFP-transduced FVB strain of protein-iPS cells were injected into ICR tetraploid blastocysts. At E10.5, embryos were harvested and genotyped.
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Detailed full experimental methods, materials and associated references are described in the Data Supplement.
RESULTS
Generation of pluripotent stem cells from adult fibroblasts
We cultured primary cardiac fibroblast (cFB) from an adult C57/BL mouse. To exclude potential resident stem cells, e.g. adult cardiac stem cell, we collected c-kit (-) cells and cultured them to at least passage 4 before inducing reprogramming. We checked the cFBs did not exhibit stem or progenitor cells' characteristics ( Figure 1A and 1B) .
We first tested the efficacy of streptolysin O-mediated reversible permeabilization using fluorescent dextran (Figure 1C and 1D) . We confirmed intracellular fluorescence stay of 10, 40 and 70 kDa dextran upto 7 days after a single transfer and resealing procedure, indicating that transferred materials would last intracellularly for a certain period of time.
The protocol for reprogramming by proteins is shown in Figure 1E . We introduced C57
background ES cell-derived extract proteins into cFB by reversible permeabilization.
When we started with 1x10 6 cFBs, we observed approximately 5-10 colonies from day 4 to 7 after induction. On day 10, we disaggregated the colonies into a single cell and reseeded the cell onto supporting feeder cell layers. We observed numerous secondary colonies, which were similar to the ES cell colonies in morphology, on the feeder layers, 10 to 15 days after reseeding (day 20-25 from induction) ( Figure 1F) . The ES-like cells (colonies) were expanded with subculture every 3 to 5 days using the standard ES cell culture protocol. We named these ES-like cells as cFB-protein-iPS cells.
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In vitro characteristics of the protein-iPS cells shows typical features of ES cells
After 45 to 55 days of culture (passage 5-7), we carried out several assays to compare the cFB-protein-iPS with ES cell that is the donor of extract proteins. Both of cFBprotein-iPS and ES colonies exhibited comparably strong alkaline phosphatase (ALP) activity whereas cFB showed very weak ALP activity (Figure 1G ).
Immunocytochemistry revealed that the cFB-protein-iPS cells expressed pluripotency markers including SSEA1 and Oct4 ( Figure 1H ). The RT-PCR showed that the cFBprotein-iPS expressed typical pluripotent ES cell genes, such as Nanog, Oct4, Sox2, and E-Ras at consistent levels compared with the ES cell, whereas the cFB and feeder cell did not express these genes ( and protein-iPS cells are at least 10,000-fold higher than those in fibroblasts.
Next, we performed a microarray analysis to assess the global gene expression profiles.
Scatter plots demonstrated that the cFB-protein-iPS was very different from the cFB, and cFB-protein-iPS had an ES-like global gene expression pattern (Figure 2B ).
Hierarchical clustering also showed a similarity between the cFB-protein-iPS and ES cell, but not between the cFB-protein-iPS and the cFB (Figure 2C) . In detail, the profile of differentially expressed genes (DEG) selected by a fold change of >2 revealed that 3,824 genes were differently expressed when cFB was compared to cFB-protein-iPS, In addition to the global gene expression level, epigenetic modifications are critical for reprogramming and dedifferentiation up to the pluripotent state. 27, 31 Therefore, we evaluated DNA at the methylation level. Bisulfite genomic sequencing analysis showed that the promoter regions of Oct4 and Nanog were largely unmethylated in both cFBprotein-iPS and ES cell, but not in cFB ( Figure 2D) . Additionally, we examined two other promoter regions, Lamin A and B1, and found that both promoters were largely 2) . We also assessed the histone modification status. 2 The ChIP assays of the Oct4 and Nanog promoters showed that cFB-protein-iPS had histone H3 lysine 4 (H3K4) methylation, whereas the cFB had histone H3 lysine 27 (H3K27) methylation (Figure 2E) . Furthermore, cFB-protein-iPS showed increased acetylation of histone H3 of Oct4 and Nanog promoters, whereas cFB decreased (Supplemental 
In vitro and in vivo differentiation potentials of protein-iPS cells
To determine the differentiation potential of the cFB-protein-iPS, we used the embryoid body (EB)-based spontaneous differentiation protocol. After 7 days of suspension, the cFB-protein-iPS formed cell-aggregates that looked like typical EBs. The ES cellderived aggregates served as a positive control (Figure 3A) . To further assess the differentiation potential, the aggregated cells (EBs) were plated onto a 0.1% gelatin- and endoderm (α-fetoprotein) lineage markers (Figure 3B and 3C) .
Next, to investigate the in vivo pluripotency and differentiation potential, cFB-protein-iPS cells were injected into NOD/SCID mice. The cFB-protein-iPS gave rise to subcutaneous mass on days 14 to 21 and well-demarcated tumors were harvested on day 28 (Figure 3D) . The tumors contained the various derivatives of the three germ layers, indicating the development of a well-differentiated teratoma (Figure 3E) . These results suggest that the cFB-protein-iPS cell is comparable to the ES cell with regard to in vitro and in vivo pluripotency.
Protein-based reprogramming is neither by the contamination of donor ES cell nor by DNAs/RNAs from donor ES cell.
The reprogramming of somatic cells into pluripotent stem cells has been generally considered a slow stochastic process, which require continuous ectopic expression the defined transcription factors in a certain period and also require multiple cell divisions 19, 32 . In contrast, we, in the present study, observed that the transfer of ES cellderived proteins reprogrammed somatic cells in the relatively short time window.
Therefore, we next made every effort to exclude the possibility of experimental artifacts. 4A ). FVB is an inbred strain. FVB strain has been widely used for the generation of transgenic animals but has considered resistant or non-permissive strain for ES cell derivation. Recently, a few FVB-ES cell lines have been reported. However, only one wild type ES cell line was described germline competent, 33 whereas STAT3 overexpression in the inner cell mass achieved the germline competency of FVB strainderived ES cells. 34 These data may suggest that inbred FVB strain is optimal to test the reliability or efficacy of new reprogramming method.
After we acquired ES-like colonies from skin fibroblasts by proteins transfer, we confirmed the origin of the sFB-protein-iPS cells by multiple microsatellite markers of genomic DNA and exact size measurement (Figure 4B and 4C) . sFB-protein-iPS cell is a FVB background. Furthermore, to verify chromosomal stability after reprogramming as well as to rule out the addition of ES cell chromosomes to protein-iPS cells, we karyotyped the cells and confirmed diploidy (Figure 4D) . We further characterized FVB Next, to demonstrate that ES extract-mediated reprogramming is dependent upon proteins, we first checked for DNA or RNA contamination in the ES-derived extract ( Figure 6A and 6B) . Second, to further exclude the possibility of contamination by genetic material or RNA, we treated the extract with DNAse or RNAse prior to transfer.
In a series of experiments, we used Oct-4 promoter-driven GFP expressing fibroblast as a reporter. To verify proteins are an effector, we also inactivated the extract by heat ( Figure 6C ). Data showed that DNA or RNA from ES cell has no effect on the reprogramming and that ES cell-derived proteins are wholly responsible.
Early (4-7 days after protein transfer) colony formation and Oct4 expression are unique features of our approach, compared with reprogramming sequences used in previous studies based on 4-factor virus/plasmid/protein methods. Taken together, ES cell-derived proteins may have a combination of many factors like cytoplasms of meiotic oocyte and mitotic zygote, 18 which can induce pluripotency of somatic cells. Future studies to characterize specific effector proteins would provide insights of the mechanistic understanding of the protein-based reprogramming process.
In vivo differentiation and developmental potential of protein-iPS cells from a different genetic strain from protein-donor ES cell
To confirm pluripotency of protein-iPS cells generated by genetically unmatched ES extract proteins, we first injected FVB-sFB-protein-iPS cells into NOD/SCID mice ( Figure 7A) . Four weeks later, protein-iPS cells gave rise to well-differentiated teratomas that contained the various derivatives of the three germ layers, indicating that protein-iPS possess in vivo differentiation potential ( Figure 7B) .
Next, to assess developmental potential, we injected FVB-protein-iPS cells into a C57 blastocyst cavity and transferred into the uterus of pseudopregnant ICR mice. 24 out of 110 offspring showed white striped-agouti coat color, indicating chimaeras (Figure 7C and Supplemental stringent functional assay of pluripotency. 29, 30 We introduced diploid GFP-transduced FVB-sFB-protein-iPS cells into ICR tetraploid blastocysts. At E10.5, we harvested and genotyped the embryos (Figure 7D-7F and Supplemental Movie 2 demonstrate a beating heart of a harvested fetus). We confirmed fetal animals have been derived from FVB-background adult fibroblasts, indicating that the protein-iPS cells possess in vivo developmental potential. The generation of live-born animals from protein-based reprogrammed cells will be tested in the near future.
DISCUSSION
In the present study, we demonstrate that the delivery of embryonic stem (ES) cellderived proteins enables the reprogramming of adult fibroblasts, converting them into pluripotent stem cells without the forced expression of certain genetic factors. Our results are different in several aspects, compared to previous studies conducted using a similar protocol (Supplemental Table 5 describes detailed comparisons). 23, 24 First, we achieved full reprogramming of adult fibroblast up to the pluripotent state and redifferentiation into three germ layers in vitro and in vivo. We also demonstrated in vivo developmental potential of protein-iPS cells. Second, instead of immortalized cell lines or fetal cells used in the previous studies, we used primarily-cultured adult fibroblasts which obviously possess a limited life span; this might have resulted in the natural selection of pluripotent stem cells during the reprogramming. Third, after the initial colony formation, we sub-cultured and maintained the colonies on the feeder cell layers.
Fourth, we used C57 strain ES cells as a protein donor and initially transferred extract proteins to C57 background adult fibroblasts which are considered permissive strain for Such studies will bring us closer to the application of protein-iPS cells to therapeutic purposes.
Cell fusion studies indicated that the ES cell nucleus is needed to reprogram the protein-based reprogramming approach might be also a stochastic, rather than deterministic, process. 19 In summary, we apply protein-based reprogramming approach and demonstrate that a single transfer of proteins can induce reprogramming of adult fibroblasts, rather than using fetus-or newborn-origin cells, upto the pluripotent state. We confirmed that a certain group of ES-derived extract proteins, rather than DNA or RNA, acts as the effector of reprogramming. Our approach is relatively simple and reproducible, and does not require repeated transfer or prolonged exposure to materials, or a combinatorial approach involving proteins and chemicals. These results provide a safe and effective alternative strategy for reprogramming of adult somatic cells, and suggest that the described technique could be further developed to provide tailored-or patientspecific cell therapy. Immunocytochemistry revealed the expression of three-germ layer marker proteins. E. Genomic DNA PCR showed the origin of fetus is FVB background protein-iPS cells.
F. The accurate sizes of amplified products were confirmed using fluorescent primers.
